1.
|
17 p, 2.5 MB |
Cervical Fluids Are a Source of Protein Biomarkers for Early, Non-Invasive Endometrial Cancer Diagnosis
/
Martinez-Garcia, Elena (Luxembourg Institute of Health) ;
Coll de la Rubia, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lesur, Antoine (Luxembourg Institute of Health) ;
Dittmar, Gunnar (University of Luxembourge) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron) ;
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Abnormal uterine bleeding (AUB) is the main symptom of endometrial cancer (EC), but it is highly nonspecific. This represents a huge burden for women's health, since all women presenting with bleeding will undergo sequential invasive tests, avoidable in 90-95% of those women who do not have EC. [...]
2023 - 10.3390/cancers15030911
Cancers, Vol. 15 (january 2023)
|
|
2.
|
0 p, 0 bytes |
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer
/
Vrede, Stephanie W. (Canisius-Wilhelmina Hospital) ;
Kasius, Jenneke (Amsterdam Medical Centers and Center of Gynecologic Oncology Amsterdam) ;
Bulten, Johan (Radboud University Medical Center) ;
Teerenstra, Steven (Radboud University Medial Center) ;
Huvila, Jutta (University of Turku) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron) ;
Boll, Dorry (Catharina Hospital Eindhoven, the Netherlands) ;
Vos, Maria Caroline (Elisabeth-Tweesteden Hospital) ;
van Altena, Anne M. (Radboud University Medical Center) ;
Asberger, Jasmin (Medical Center-University of Freiburg) ;
Sweegers, Sanne (Radboud University Medical Center) ;
van Weelden, Willem Jan (Canisius-Wilhelmina Hospital) ;
van der Putten, Louis J. M. (Radboud University Medical Center) ;
Amant, Frederic (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Visser, Nicole C. M. (Stichting Laboratory for Pathology and Medical Microbiology) ;
Snijders, Marc P. L. M. (Canisius-Wilhelmina Hospital) ;
Küsters-Vandevelde, Heidi V. N. (Canisius Wilhelmina Hospital) ;
Kruitwagen, Roy (Maastricht University Medical Center) ;
Matias-Guiu, Xavier (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
Weinberger, Vit (University Hospital in Brno and Masaryk University) ;
Reijnen, Casper (Radboud University Medical Center) ;
Pijnenborg, Johanna M. A. (Radboud University Medical Center) ;
Universitat Autònoma de Barcelona
Is tumor molecular profile associated with outcomes among patients with low-grade endometrial cancer? In this retrospective multicenter cohort study of 393 patients, outcomes for patients with low-grade endometrial cancer were not associated with molecular subgroup. [...]
2022 - 10.1001/jamanetworkopen.2022.47372
JAMA network open, Vol. 5 (december 2022)
|
|
3.
|
20 p, 10.3 MB |
The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival
/
Diéguez-Martínez, Nora (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Espinosa-Gil, Sergio (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Yoldi Salinas, Guillermo (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Megías-Roda, Elisabet (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Bolinaga-Ayala, Idoia (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Viñas-Casas, Maria (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Gorgisen, Gokhan (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Domingo-Ortí, Inés (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Pérez-Montoyo, Héctor (Ability Pharmaceuticals (Cerdanyola del Vallès)) ;
Bayascas Ramírez, José Ramón (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Dolcet, Xavier (Universitat de Lleida) ;
Lizcano de Vega, José Miguel (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Endometrial cancer (EC) is the most common type of gynecologic cancer in women of developed countries. Despite surgery combined with chemo-/radiotherapy regimens, overall survival of patients with high-risk EC tumors is poor, indicating a need for novel therapies. [...]
2022 - 10.1007/s00018-022-04541-6
Cellular and Molecular Life Sciences, Vol. 79 (2022) , p. 524
|
|
4.
|
16 p, 5.4 MB |
Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression
/
Mota, Alba (Universidad Autónoma de Madrid. Departamento de Bioquímica) ;
Oltra, Sara S. (Centro de Investigación Biomédica en Red de Cáncer) ;
Selenica, Pier (Memorial Sloan Kettering Cancer Center) ;
Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Casas-Arozamena, Carlos (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
López-Gil, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Diaz, Eva (MD Anderson International Foundation) ;
Gatius, Sonia (Hospital Arnau de Vilanova (València)) ;
Ruiz-Miro, María (Biobank (Lleida)) ;
Calvo, Ana (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
Rojo-Sebastián, Alejandro (MD Anderson Cancer Center) ;
Hurtado Blanco, P (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Piñeiro, Health Research Institute of Santiago de Compostela ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron) ;
Reis-Filho, Jorge S. (Memorial Sloan Kettering Cancer Center.) ;
Muinelo-Romay, Laura (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Abal Posada, Miguel (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Matias-Guiu, Xavier (Universitat de Lleida) ;
Weigelt, Britta (Memorial Sloan Kettering Cancer Center. Department of Pathology) ;
Moreno-Bueno, Gema (Centro de Investigación Biomédica en Red de Cáncer) ;
Universitat Autònoma de Barcelona
Analyzing different tumor regions by next generation sequencing allows the assessment of intratumor genetic heterogeneity (ITGH), a phenomenon that has been studied widely in some tumor types but has been less well explored in endometrial carcinoma (EC). [...]
2022 - 10.1038/s41388-022-02221-0
Oncogene, Vol. 41 (february 2022) , p. 1835-1850
|
|
5.
|
16 p, 1.3 MB |
Molecular Markers for Prostate Cancer in Formalin-Fixed Paraffin-Embedded Tissues
/
Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
García, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Olivan, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
de Torres, Inés (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Morote Robles, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Reventós Puigjaner, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Prostate cancer (PCa) is the most frequently diagnosed type of cancer in developed countries. The decisive method of diagnosis is based on the results of biopsies, morphologically evaluated to determine the presence or absence of cancer. [...]
2013 - 10.1155/2013/283635
BioMed Research International, Vol. 2013 (november 2013)
|
|
6.
|
13 p, 2.0 MB |
Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis
/
Altadill, Tatiana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Dowdy, Tyrone M. (Georgetown University Medical Center) ;
Gill, Kirandeep (Georgetown University Medical Center) ;
Reques, Armando (Hospital Universitari Vall d'Hebron) ;
Menon, Smrithi S. (Georgetown University Medical Center) ;
Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lopez-Gil, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Coll de la Rubia, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Matias-Guiu, Xavier (Institut d'Investigació Biomèdica de Bellvitge) ;
Cabrera Díaz, Silvia (Vall d'Hebron Institut d'Oncologia) ;
Garcia, Angel (Hospital Universitari Vall d'Hebron) ;
Reventos, Jaume (Universitat Internacional de Catalunya) ;
Byers, Stephen W. (Georgetown-Lombardi Comprehensive Cancer Center) ;
Gil-Moreno, Antonio 1965- (Vall d'Hebron Institut d'Oncologia) ;
Cheema, Amrita K. (Georgetown-Lombardi Comprehensive Cancer Center) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Endometrial cancer (EC) remains the most common malignancy of the genital tract among women in developed countries. Although much research has been performed at genomic, transcriptomic and proteomic level, there is still a significant gap in the metabolomic studies of EC. [...]
2017 - 10.1038/s41598-017-09169-2
Scientific reports, Vol. 7 (august 2017)
|
|
7.
|
26 p, 789.4 KB |
Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer
/
Megino-Luque, Cristina (Centro de Investigación Biomédica en Red de Cáncer) ;
Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Molins-Escuder, Clara (Universitat de Lleida) ;
López-Gil, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Matias-Guiu, Xavier (Institut d'Investigació Biomèdica de Bellvitge) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Eritja, Núria (Institut de Recerca Biomèdica de Lleida) ;
Universitat Autònoma de Barcelona
Patients diagnosed with endometrial cancer (EC), the most common gynaecological malignancy in women worldwide, cope with a disease associated with poor prognosis and limited treatment options after first-line therapy when it reaches an advanced or metastatic stage. [...]
2020 - 10.3390/cancers12102751
Cancers, Vol. 12 (september 2020)
|
|
8.
|
20 p, 2.0 MB |
Prognostic Biomarkers in Endometrial Cancer : A Systematic Review and Meta-Analysis
/
Coll de la Rubia, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martinez-Garcia, Elena (Quantitative Biology Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg; (E.M.-G.); (G.D.)) ;
Dittmar, Gunnar (Quantitative Biology Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg; (E.M.-G.); (G.D.)) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Endometrial cancer (EC) is the sixth most common cancer in women worldwide and its mortality is directly associated with the presence of poor prognostic factors driving tumor recurrence. Stratification systems are based on few molecular, and mostly clinical and pathological parameters, but these systems remain inaccurate. [...]
2020 - 10.3390/jcm9061900
Journal of clinical medicine, Vol. 9 (june 2020)
|
|
9.
|
16 p, 3.4 MB |
Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
/
Casas-Arozamena, Carlos (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Diaz, Eva (Foundation MD Anderson International (Madrid)) ;
Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Alonso-Alconada, Lorena (Nasasbiotech (La Coruña)) ;
Ferreiros, Alba (Nasasbiotech (La Coruña)) ;
Abalo, Alicia (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
López Gil, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Oltra, Sara S. (Foundation MD Anderson International (Madrid)) ;
de Santiago, Javier (Department of Gynecology, MD Anderson Cancer Center, 28029 Madrid, Spain) ;
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sampayo, Victoria (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Bouso, Marta (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Arias, Efigenia (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Cueva, Juan (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Colás Ortega, Eva (Centro de Investigación Biomédica en Red de Cáncer) ;
Vilar, Ana (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Gil-Moreno, Antonio 1965- (Centro de Investigación Biomédica en Red de Cáncer) ;
Abal Posada, Miguel (Centro de Investigación Biomédica en Red de Cáncer) ;
Moreno-Bueno, Gema (University of Madrid) ;
Muinelo-Romay, Laura (Centro de Investigación Biomédica en Red de Cáncer) ;
Universitat Autònoma de Barcelona
The incidence and mortality of endometrial cancer (EC) have risen in recent years, hence more precise management is needed. Therefore, we combined different types of liquid biopsies to better characterize the genetic landscape of EC in a non-invasive and dynamic manner. [...]
2020 - 10.3390/jcm9020585
Journal of clinical medicine, Vol. 9 (february 2020)
|
|
10.
|
14 p, 1.3 MB |
Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools
/
Besso, María josé (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ;
Montivero, Luciana (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ;
Lacunza, Ezequiel (Centro de Investigaciones Inmunológicas, Básicas y Aplicadas, Facultad de Ciencias Médicas, Universidad Nacional de La Plata) ;
Argibay, María cecilia (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ;
Abba, Martín (Centro de Investigaciones Inmunológicas, Básicas y Aplicadas, Facultad de Ciencias Médicas, Universidad Nacional de La Plata) ;
Furlong, Laura I (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Reventos, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Bello, Ricardo (Departamento de Metodología, Estadística y Matemática, Universidad de Tres de Febrero) ;
Vazquez-Levin, Mónica Hebe (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ;
Universitat Autònoma de Barcelona
Endometrial cancer (EC) is the sixth most common cancer in women worldwide. Early diagnosis is critical in recurrent EC management. The present study aimed to identify biomarkers of EC early recurrence using a workflow that combined text and data mining databases (DisGeNET, Gene Expression Omnibus), a prioritization algorithm to select a set of putative candidates (ToppGene), protein-protein interaction network analyses (Search Tool for the Retrieval of Interacting Genes, cytoHubba), association analysis of selected genes with clinicopathological parameters, and survival analysis (Kaplan-Meier and Cox proportional hazard ratio analyses) using a The Cancer Genome Atlas cohort. [...]
2020 - 10.3892/or.2020.7648
Oncology Reports, Vol. 44 (june 2020) , p. 873-886
|
|